Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosaku Murakami

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Immunological Medicine|April 30, 2026
Comprehensive management of immune-related adverse events: predictive strategies, mechanistic insights, and therapeutic approachesKosaku Murakami
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|June 21, 2016
Potential of specialized pro-resolving lipid mediators against rheumatic diseasesKosaku Murakami
Clinical Calcium|May 8, 2018
[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. The Pathophysiology in Rheumatoid Arthritis.]Kosaku Murakami, Tsuneyo Mimori
Internal Medicine (Tokyo, Japan)|August 28, 2018
Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related DisordersKosaku Murakami, Tsuneyo Mimori
Rheumatology (Oxford, England)|July 16, 2025
Comment on: NK cell cytotoxicity is markedly reduced in younger patients with RA treated with JAK inhibitorsTsuneyasu Yoshida, Yuuki Sato, Kosaku Murakami
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 11, 2012
[Rheumatoid arthritis: progress in diagnosis and treatment. Topics: II. Pathophysiology; 3. Autoantibodies in rheumatoid arthritis]Kosaku Murakami, Takao Fujii, Tsuneyo Mimori
Immunological Medicine|October 1, 2025
Effect of organism aging on the development of anti-PD-(L)1 therapy-associated adverse eventsHirotake Tsukamoto, Kosaku Murakami, Yuji Miura, et al.
The Journal of Dermatology|June 11, 2021
Unique cutaneous features in a case of anti-nuclear matrix protein 2 antibody positive-dermatomyositisKaori Shima, Saeko Nakajima, Shunya Usui, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|October 10, 2014
P2-006　　profiles of receptors for specialized lipid mediators on synoviocyte from osteoarthritisKosaku Murakami, Andreea Ioan-Facsinay, Rene Toes, et al.
European Journal of Immunology|August 27, 2014
Functional engraftment of human peripheral T and B cells and sustained production of autoantibodies in NOD/LtSzscid/IL-2Rγ(-/-) miceYuki Ishikawa, Takashi Usui, Aoi Shiomi, et al.
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Immunological Medicine|April 30, 2026
Comprehensive management of immune-related adverse events: predictive strategies, mechanistic insights, and therapeutic approachesKosaku Murakami
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|June 21, 2016
Potential of specialized pro-resolving lipid mediators against rheumatic diseasesKosaku Murakami
Clinical Calcium|May 8, 2018
[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. The Pathophysiology in Rheumatoid Arthritis.]Kosaku Murakami, Tsuneyo Mimori
Internal Medicine (Tokyo, Japan)|August 28, 2018
Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related DisordersKosaku Murakami, Tsuneyo Mimori
Rheumatology (Oxford, England)|July 16, 2025
Comment on: NK cell cytotoxicity is markedly reduced in younger patients with RA treated with JAK inhibitorsTsuneyasu Yoshida, Yuuki Sato, Kosaku Murakami
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 11, 2012
[Rheumatoid arthritis: progress in diagnosis and treatment. Topics: II. Pathophysiology; 3. Autoantibodies in rheumatoid arthritis]Kosaku Murakami, Takao Fujii, Tsuneyo Mimori
Immunological Medicine|October 1, 2025
Effect of organism aging on the development of anti-PD-(L)1 therapy-associated adverse eventsHirotake Tsukamoto, Kosaku Murakami, Yuji Miura, et al.
The Journal of Dermatology|June 11, 2021
Unique cutaneous features in a case of anti-nuclear matrix protein 2 antibody positive-dermatomyositisKaori Shima, Saeko Nakajima, Shunya Usui, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|October 10, 2014
P2-006　　profiles of receptors for specialized lipid mediators on synoviocyte from osteoarthritisKosaku Murakami, Andreea Ioan-Facsinay, Rene Toes, et al.
European Journal of Immunology|August 27, 2014
Functional engraftment of human peripheral T and B cells and sustained production of autoantibodies in NOD/LtSzscid/IL-2Rγ(-/-) miceYuki Ishikawa, Takashi Usui, Aoi Shiomi, et al.
Pageof 16